GeneDx Holdings Corp. Current Foreign Tax Expense (Benefit)
GeneDx Holdings Corp. (WGS) reported Current Foreign Tax Expense (Benefit) of $310.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2026-02-23
- GeneDx Holdings Corp. current foreign tax expense (benefit) for fiscal 2025 was $310.00K, a 28.63% increase from fiscal 2024.
- GeneDx Holdings Corp. current foreign tax expense (benefit) for fiscal 2024 was $241.00K, a 46.95% increase from fiscal 2023.
- GeneDx Holdings Corp. current foreign tax expense (benefit) for fiscal 2023 was $164.00K, a 127.78% increase from fiscal 2022.
- GeneDx Holdings Corp. current foreign tax expense (benefit) for fiscal 2022 was $72.00K.
| Period end | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $310.00K 10-K · filed 2026-02-23 |
| 2024-12-31 | $241.00K 10-K · filed 2026-02-23 |
| 2023-12-31 | $164.00K 10-K · filed 2026-02-23 |
| 2022-12-31 | $72.00K 10-K · filed 2024-02-23 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |
| 2020-12-31 | $0.00 10-K · filed 2023-03-16 |
| 2019-12-31 | $0.00 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |